Piper Sandler lowered the firm’s price target on UnitedHealth (UNH) to $417 from $423 and keeps an Overweight rating on the shares. The firm would be a buyer of UnitedHealth on Q3 beat and raise. Execution at the company gives Piper visibility into, and confidence in, accelerating earnings growth over the next 2 years. Optum Health overhaul is also underway, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Enrollees of ACA plans learn of hefty premium increases, WSJ reports
- Deutsche Bank downgrades UnitedHealth to Hold on valuation
- UnitedHealth downgraded to Hold from Buy at Deutsche Bank
- UnitedHealth Group’s Q3 2025 Results and Outlook
- UnitedHealth Group’s Earnings Call Highlights Growth and Challenges